Overcoming Imatinib resistance using CAI, a calcium-mediated signal transduction inhibitor: A new therapeutic strategy for chronic myelogenous leucemia
- Authors: Corrado,C; Fontana, S,; Giordano, M; Colomba, P; Raimondo, S; Arlinghaus, RB; Kohn, EC; De Leo, G; Alessandro, R
- Publication year: 2008
- Type: Proceedings
- Key words: Imatinib resistance; carboxyamdotriazole; Chronic Myelogenous Leukemia
- OA Link: http://hdl.handle.net/10447/44408